Evidence map›Paper›PMID 36846000›Full record

ArticleAnnals of translational medicine2023

Exploring the molecular targets and mechanism of

Hong Yu, Lan Zhang, Fei Yin, Chaowu Zhan, Jie Chen, Jijun Chu

Abstract read
In one paragraph

Article in Annals of translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Relationship between different modes of death and premature ovarian insufficiency: a literature review.Apoptosis : an international journal on programmed cell death · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hong YuDepartment of Reproductive Medicine, The Second People's Hospital of Wuhu, Wuhu, China.
Lan ZhangDepartment of Reproductive Medicine, The Second People's Hospital of Wuhu, Wuhu, China.
Fei YinDepartment of Reproductive Medicine, The Second People's Hospital of Wuhu, Wuhu, China.
Chaowu ZhanDepartment of Reproductive Medicine, The Second People's Hospital of Wuhu, Wuhu, China.
Jie ChenDepartment of Reproductive Medicine, The Second People's Hospital of Wuhu, Wuhu, China.
Jijun ChuDepartment of Reproductive Medicine, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: The Traditional Chinese Medicine Systems Pharmacology (TCMSP) platform was employed for screening the active ingredients of Results: In the TCMSP database, we found a total of 80 active ingredients in Conclusions: This study expounds the research value of

Indexed as

bioinformaticsgene expression profilenetwork pharmacologyPolycystic ovary syndrome (PCOS)traditional Chinese medicine (TCM)

Identifiers

PMID36846000
PMCPMC9951011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.